Table 2. Changes in body composition, laboratory tests and atherosclerotic index before and after periods of COVID-19 pandemic.
| Pre-pandemic (2017–2019) |
Pandemic (2020–2022) |
t−test | P−value | △Mean difference (95% CI) (Pandemic to Pre−pandemic) |
|
| Mean ± SD | Mean ± SD | ||||
| Body compositions | |||||
| Body mass index, kg/m2 | 24.053 ± 2.858 | 23.947 ± 2.974 | 0.429 | 0.669 | −0.106 (−0.386–0.600) |
| Body weight, kg | 65.416 ± 10.605 | 64.778 ± 10.285 | 0.687 | 0.493 | −0.6382 (−2.474–1.197) |
| Body fat mass, g/cm³ | 25.012 ± 5.931 | 26.027 ± 6.022 | −2.166 | 0.003 | 1.014 (0.885–1.940) |
| Muscle mass, kg | 45.220 ± 7.779 | 44.131 ± 7.496 | 1.775 | 0.000 | −1.727 (−2.557–−0.897) |
| Waist circumference, cm | 85.493 ± 9.031 | 85.972 ± 8.646 | −0.584 | 0.005 | 0.4792 (−1.14–2.099) |
| Laboratory tests | |||||
| Total cholesterol, mmol/L | 178.531 ± 37.667 | 171.614 ± 36.267 | 1.723 | 0.087 | −6.917 (−14.850–1.016) |
| High−density lipoprotein cholesterol, mmol/L | 55.428 ± 16.578 | 57.752 ± 15.706 | −1.386 | 0.168 | 2.324 (−0.990–5.639) |
| Low−density lipoprotein cholesterol, mmol/L | 119.710 ± 38.508 | 108.097 ± 35.622 | 3.066 | 0.003 | −11.613 (−19.102–−4.125) |
| Triglyceride, mmol/L | 111.338 ± 74.280 | 107.097 ± 70.9097 | 0.585 | 0.560 | −4.241 (−18.583–10.101) |
| Glycated hemoglobin A1c, % | 6.213 ± 0.945 | 6.065 ± 0.691 | 1.990 | 0.049 | −0.147 (−0.294–−0.000) |
| Atherosclerotic measures | |||||
| Ankle−brachial index | 1.115 ± 0.084 | 1.027 ± 0.005 | 9.773 | 0.000 | −0.886 (−0.106–−0.007) |
| Pulse wave velocity (Rt), m/s | 1595.786 ± 278.301 | 1727.021 ± 292.710 | −5.313 | 0.000 | 131.234 (82.409–180.059) |
| Pulse wave velocity (Lt), m/s | 1589.814 ± 270.285 | 1736.883 ± 319.620 | −5.712 | 0.000 | 147.069 (96.180–197.957) |